INVESTIGATING THE RELATIONSHIP BETWEEN DAILY DISEASE IMPACT SCORES AND MOOD IN PATIENTS WITH PSORIATIC ARTHRITIS USING A SMARTPHONE APPLICATION: A NOVEL USE OF THE PsAID-9 QUESTIONNAIRE

被引:0
|
作者
McGagh, Dylan [1 ]
McGowan, Niall [2 ]
Wu, Yuhao [3 ]
Hinds, Chris [3 ]
Saunders, Kate E. A. [4 ]
Coates, Laura C. [1 ]
机构
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[2] Univ Oxford, Sleep & Circadian Neurosci Inst, Nuffield Dept Clin Neurosci, Oxford, England
[3] Univ Oxford, Big Data Inst, Oxford Digital Phenotyping Lab, Oxford, England
[4] Univ Oxford, Dept Psychiat, Oxford, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E085
引用
收藏
页数:2
相关论文
共 5 条
  • [1] Defining Cutoffs Corresponding to Low Levels of Disease Activity in Psoriatic Arthritis, Using the Patient-Reported Psoriatic Arthritis Impact of Disease Questionnaire (PsAID12). an Analysis of 436 Patients
    Gorlier, Clemence
    Puyraimond-Zemmour, Deborah
    Orbai, Ana-Maria
    Coates, Laura C.
    Kiltz, Uta
    Leung, Ying Ying
    Palominos, Penelope
    Canete, Juan D.
    Scrivo, Rossana
    Balanescu, Andra Rodica
    Dernis, Emmanuelle
    Talli, Sandra
    Ruyssen-Witrand, Adeline
    Soubrier, Martin
    Aydin, Sibel Zehra
    Eder, Lihi
    Gaydukova, Inna
    Lubrano, Ennio
    Richette, Pascal
    Husni, M. Elaine
    de Wit, Maarten
    Smolen, Josef S.
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] Relationship between disease impact scores and C-reactive protein/albumin ratio in patients with psoriatic arthritis
    Duran, Tugba Izci
    Pamukcu, Melih
    CROATIAN MEDICAL JOURNAL, 2022, 63 (02) : 141 - 147
  • [3] PSYCHOMETRIC ASSESSMENT OF THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM THE PHASE 3 BE OPTIMAL AND BE COMPLETE TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L. C.
    Orbai, A. M.
    Pelligra, C.
    Lambert, J.
    Ciaravino, V
    Ink, B.
    Taieb, V
    Gladman, D. D.
    VALUE IN HEALTH, 2023, 26 (06) : S323 - S323
  • [4] IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L.
    Orbai, A. M.
    De Wit, M.
    Pelligra, C.
    Lambert, J.
    Ciaravino, V.
    Ink, B.
    Taieb, V.
    Gladman, D. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 565 - 566
  • [5] BIMEKIZUMAB TREATMENT RESULTED IN CLINICALLY MEANINGFUL IMPROVEMENTS IN THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) SCORES USING POOLED RESULTS FROM TWO PHASE 3 TRIALS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L.
    Orbai, A. M.
    De Wit, M.
    Lambert, J.
    Ink, B.
    Taieb, V.
    Gladman, D. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1130 - 1130